Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Energenesis Biomedical Co., Ltd. (6657) Income Statement

Energenesis Biomedical Co., Ltd. Income Statement

Last quarter (Q2 2026), Energenesis Biomedical Co., Ltd.'s total revenue was NT$1.85M, a decrease of 10.27% from the same quarter last year. In Q2, Energenesis Biomedical Co., Ltd.'s net income was NT$-138.50M. See Energenesis Biomedical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 7.67MNT$ 7.75MNT$ 7.16MNT$ 7.35MNT$ 7.49M
NT$ 5.83MNT$ 5.69MNT$ 5.23MNT$ 5.17MNT$ 5.36M
NT$ 281.11MNT$ 260.86MNT$ 267.06MNT$ 276.82MNT$ 127.45M
Depreciation and AmortizationNT$ 22.57MNT$ 22.80MNT$ 23.82MNT$ 24.41MNT$ 22.90M
NT$ -252.70MNT$ -208.06MNT$ -238.02MNT$ -241.04MNT$ -97.05M
NT$ -275.27MNT$ -255.17MNT$ -261.84MNT$ -265.45MNT$ -119.95M
NT$ 16.87MNT$ 24.09MNT$ 1.46MNT$ 5.99MNT$ 1.85M
NT$ -258.40MNT$ -231.08MNT$ -260.38MNT$ -265.66MNT$ -120.24M
NT$ -258.40MNT$ -231.08MNT$ -260.38MNT$ -265.66MNT$ -120.24M
Per Share Metrics
Basic EPSNT$ -2.92NT$ -3.01NT$ -3.62NT$ -3.99NT$ -2.00
Diluted EPSNT$ -2.92NT$ -3.01NT$ -3.62NT$ -3.99NT$ -2.00
Weighted Average Shares Outstanding88.49M76.65M71.93M66.63M60.05M
Weighted Average Shares Outstanding (Diluted)88.49M76.65M71.93M66.63M60.05M

Currency in TWD

Energenesis Biomedical Co., Ltd. Earnings and Revenue History

-300M-150M0150M-4000 %-3000 %-2000 %-1000 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin